Engin Köse

Dr. Engin Köse

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2020 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
EKEngin Köse
Engin Köse
OBOzge Besci
Ozge Besci
EGElif Gudeloglu
Elif Gudeloglu
SSSuzan Suncak
Suzan Suncak
YOYesim Oymak
Yesim Oymak
RIRana Isguder
Rana Isguder
Objectives: Transcobalamin II (TC) is an essential plasma protein for the absorption, transportation, and cellular uptake of cobalamin. TC deficiency presents in the first year of life with failure to thrive, hypotonia, lethargy, diarrhea, pallor, mucosal ulceration, anemia, pancytopenia, and agammaglobulinemia. Herein, we present TC deficiency diagnosed in two cases (twin siblings) with a novel variant in the TCN2 gene. Case presentation: 4-month-old twins were admitted with fever, respiratory distress, vomiting, diarrhea, and failure to thrive. Physical examination findings revealed developmental delay and hypotonia with no head control, and laboratory findings were severe anemia, neutropenia, and hypogammaglobulinemia. Despite normal vitamin B12 and folate levels, homocysteine and urine methylmalonic acid levels were elevated in both patients. Bone marrow examinations revealed hypocellular bone marrow in both cases. The patients had novel pathogenic homozygous c.241C>T (p.Gln81Ter) variant in the TCN2 gene. In both cases, with intramuscular hydroxycobalamin therapy, laboratory parameters improved, and a successful clinical response was achieved. Conclusions: In infants with pancytopenia, growth retardation, gastrointestinal manifestations, and immunodeficiency, the inborn error of cobalamin metabolism should be kept in mind. Early diagnosis and treatment are crucial for better clinical outcomes. What is new? In literature, to date, less than 50 cases with TC deficiency were identified. In this report, we presented twins with TCN2 gene mutation. Both patients emphasized that early and aggressive treatment is crucial for achieving optimal outcomes. In this report, we identified a novel variation in TCN2 gene.

1 January 2018 in Journal of Pediatric Nursing
Verified
Journal Article
Closed access
EKEngin Köse
Engin Köse
BABetul Aksoy
Betul Aksoy
PKPinar Kuyum
Pinar Kuyum
NTNilhan Tuncer
Nilhan Tuncer
NANur Arslan
Nur Arslan
YOYesim Ozturk
Yesim Ozturk

15 March 2016 in Journal of Tropical Pediatrics
Verified
Journal Article
Open access
PDF file
EKEngin Köse
Engin Köse
SKSeda Sirin Kose
Seda Sirin Kose
DADeniz Akca
Deniz Akca
KYKerem Yildiz
Kerem Yildiz
CECengizhan Elmas
Cengizhan Elmas
MAMurat Anil
Murat Anil
We aimed to investigate the effect of rapid antigen detection test (RADT) in the diagnosis of streptococcal pharyngitis, its impact on antibiotic prescription decision of pediatricians and influence on reduction of antibiotic treatment costs in children with pharyngitis. The study group consisted of 223 patients who were diagnosed with pharyngitis by pediatricians. The sensitivity and specificity of RADT were 92.1% (95% Cl: 78.6–98.3%) and 97.3% (95% Cl: 93.8–99.1%), respectively. In the first assessment, before performing RADT, pediatricians decided to prescribe antibiotics for 178 (79.8%) patients with pharyngitis. After learning RADT results, pediatricians finally decided to prescribe antibiotics for 83 (37.2%) patients with pharyngitis, and antibiotic prescription decreased by 42.6%. Antibiotic costs in non-Group A streptococcus pharyngitis, Group A streptococcus pharyngitis and all subjects groups decreased by 80.8%, 48%, and 76.4%, respectively. Performing RADT in children with pharyngitis has an important impact on treatment decision of clinicians, reduction of unnecessary antibiotic prescriptions and antibiotic costs.

25 October 2021 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
FEFatma Tuba Eminoğlu
Fatma Tuba Eminoğlu
UOUmmuhan Oncul
Ummuhan Oncul
FKFevzi Kahveci
Fevzi Kahveci
EOEmel Okulu
Emel Okulu
EKElvis Kraja
Elvis Kraja
TKTANIL KENDIRLI
TANIL KENDIRLI

1 August 2017 in Clinical Biochemistry
Verified
Journal Article
Closed access
EKEngin Köse
Engin Köse
ÖÜÖzlem Ünal
Özlem Ünal
SBSelda Bulbul
Selda Bulbul
MGMehmet Gunduz
Mehmet Gunduz
JHJohannes Häberle
Johannes Häberle
NANur Arslan
Nur Arslan

20 September 2023 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
IKİlknur Sürücü Kara
İlknur Sürücü Kara
EKEngin Köse
Engin Köse
MYMerve Koç Yekedüz
Merve Koç Yekedüz
FEFatma Tuba Eminoğlu
Fatma Tuba Eminoğlu
Objectives In the present study, we aimed to evaluate the genotype-phenotype relation in patients with biotinidase enzyme deficiency based on repeated biotinidase enzyme measurements. Methods The hospital file information of patients with biotinidase, enzyme deficiency was assessed retrospectively, and the relationship between the BTD gene mutations analysis results and biotinidase enzyme activity following the first and repeated enzyme activity assessments was analyzed. Results One-hundred-ten patients were included. In the first enzyme evaluation, profound biotinidase enzyme deficiency was identified in 15 (13.6 %), partial biotinidase enzyme deficiency in 63 (57.3 %), and heterozygous biotinidase enzyme deficiency in 32 (29.1 %) of the patients. The BTD genetic analysis revealed 42 (38.2 %) homozygous, 42 (38.2 %) heterozygous, and 26 (23.6 %) compound heterozygous variants. The most common homozygous variant, p.Asp444His, was evaluated with 130 repeated enzyme measurements and was consistent with a partial biotinidase enzyme deficiency in 55.4 % of cases, heterozygous biotinidase enzyme deficiency in 43.8 % of cases, and profound biotinidase enzyme deficiency in one (0.8 %) case. Clinical symptoms developed in 17 patients during follow-up, of which 70.6 % were related to neurodevelopment. The most common variant was homozygous p.Asp444His (29.4 %) among the patients who developed symptoms. Conclusions This is the first study to date to evaluate the genotype-phenotype relationship in patients with biotinidase deficiency through repeated measurements of biotinidase enzyme activity. The study reveals that biotinidase enzyme activity alone is inadequate for diagnosing biotinidase enzyme deficiency or evaluating disease severity, as genetic investigations are also required for a definitive diagnosis of biotinidase enzyme deficiency.